Sun Pharmaceutical Industries Ltd. — Share Issue/Capital Change 2021

Feb 22, 2021

Sun Pharmaceutical Industries Limited Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai – 400 063, Maharashtra, INDIA. Tel. : (91-22) 4324 4324 Fax : (91-22) 4324 4343 Website: www.sunpharma.com CIN: L24230GJ1993PLC019050

==> picture [67 x 73] intentionally omitted <==

February 22, 2021

National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, 5th Floor, Market Operations Dept. Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai - 400 001. NSE Code: SUNPHARMA Stock Code: 524715

Dear Sirs,

Sub: Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of loss of share certificates/request for issue of duplicate share certificate reported by shareholder of the Company, received from our Registrar and Transfer Agent, Link Intime India Private Limited on February 20, 2021.

Sr.No.	Folio No.	Name of the Shareholder	ShareCertificateNo.	Share Distinctive Nos.	Share Distinctive Nos.	No. ofsharesofRe.1each
1	014334	SYMA KANTA BAGCHI	51385	1036154001	1036154180	180

This is for your information and record.

Thanking you, Yours faithfully,

For Sun Pharmaceutical Industries Limited

Digitally signed by Ashok Ashok Indulal Bhuta Indulal Bhuta Date: 2021.02.22 11:40:39 +05'30'

Ashok Bhuta Sr. GM – Secretarial & Compliance Officer

Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.

Reaching People. Touching Lives.